Clinical Trial Update: Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of abatacept in patients with primary Sjögren's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Sjögren's Syndrome | Phase 3 | Status: COMPLETED